Previous Close | 1.9900 |
Open | 1.9500 |
Bid | 1.9300 x 800 |
Ask | 1.9400 x 800 |
Day's Range | 1.9000 - 1.9900 |
52 Week Range | 1.9000 - 198.0000 |
Volume | |
Avg. Volume | 938,423 |
Market Cap | 2.844M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -61.9500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 210.00 |
SAN FRANCISCO, September 20, 2023--Tivic Health® Systems, Inc. (Nasdaq: TIVC) ("Tivic" or the "Company"), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, announced today that it has received notice from The NASDAQ Stock Market LLC (NASDAQ) informing Tivic that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market and that it is in compliance wi
SAN FRANCISCO, August 28, 2023--Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that the Company has entered into a non-exclusive agreement with AmerisourceBergen, soon to be Cencora, to make Tivic’s products available on AmerisourceBergen’s third-party marketplace.
SAN FRANCISCO, August 22, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC) ("Tivic" or the "Company), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, announced today that its Board of Directors has declared a 1-for-100 reverse stock split of the company’s issued and outstanding shares of common stock. The reverse stock split will become effective on August 23, 2023 (the "Effective Date") at 12:01 AM Eastern Time. The company’s commo